Press Release Dexcom CONNECT Study: The Most Significant Clinical Study Demonstrating CGM Benefits for People with Type 2 Diabetes Not Using Insulin 6 June 2026
Press Release Kalloghlian Myers LLP: Potential Investor Class Action Against TerraVest Industries Inc. 6 June 2026
Press Release Robust Phase 2b Efficacy and Favorable Tolerability Support Monthly Dosing for Pfizer’s GLP-1 RA Berobenatide 6 June 2026
Press Release Insulet Reveals New Data Supporting Breakthrough Omnipod® 6 and Fully Closed-Loop AID Systems Designed to Improve Outcomes, Reduce Effort, and Unlock Barriers to Care 6 June 2026
Press Release Investor Notice: Robbins LLP Informs Investors of the PicS N.V. Class Action 6 June 2026
Press Release Command the Clone Wars’™ Most Cunning Operatives in Star Wars Zero Company™, Launching August 27 6 June 2026
Press Release FINAL FANTASY VII REVELATION Announced — Experience the Journey’s End in Spring 2027 6 June 2026
Press Release FINAL FANTASY VII REVELATION Announced — Experience the Journey’s End in Spring 2027 6 June 2026
Press Release Tidepool Showcases New Real-World Clinical Data and Landmark Women’s Health Initiative at ADA 2026 5 June 2026
Press Release OrsoBio to Present Preclinical and Clinical Data from its Mitochondrial Protonophore Portfolio at the American Diabetes Association’s 2026 Scientific Sessions 5 June 2026
